🚨HUGE victory for SCLC!🚨
@FDAOncology
, under Project Orbis and the FDA Center of Excellence, grants accelerated APPROVAL for tarlatamab (Imdelltra, DLL3 BiTE)
@AmgenOncology
for relapsed small cell lung cancer after platinum-based therapy!
#LCSM
@SclcSMASHERS
@TheShieldsLab
Indiana University
@IUCancerCenter
will expand its lung cancer research through a transformative $20 million gift by Julie Wood that will advance discoveries and establish the Tom and Julie Wood Center for Lung Cancer Research.
#LCSM
#SCLC
#NSCLC
🚨 Advocacy alert 🚨 Majority patients diagnosed w/ lung cancer have:
❕fear about recurrence/PoD
❕do not receive supportive referrals
❕rely on patient support & family
Let’s help
#advocate
for our patients by early referrals to
#palliativecare
#oncopsych
#socialwork
#lcsm
Outstanding overview investigating the role of checkpoint inhibitors in
#SCLC
by
@StephenVLiu
at
#SCLC23
#lcsm
@IASLC
, addressing critical QAs including the role of CTLA-4 inhibition, PD-L1 expression in responders, and duration of IO in SCLC.
Thanks
@StephenVLiu
for the shoutout on our 🚨Pub Alert 🚨in
@JTOonline
#JTOCRR
Here’s the key 🔑 takeaways:
1️⃣ EGFR-RAD51 fusions are rare
2️⃣ osimertinib = effective/durable
3️⃣ know the coverage of
#NGS
panels
4️⃣ precision medicine changes lives
#LCSM
#liquidbiopsy
Case report from
@drshieldsmd
and team in
#JTOCRR
on 45 year old patient with NSCLC and an
#EGFR
-RAD51 fusion found on NGS. No response to 1L chemoimmunotherapy but dramatic response to osimertinib, with treatment ongoing at one year.
@JTOonline
What an incredible privilege to meet so many
#SCLC
survivors & care partners
@livelung1
#SCLCsummit2024
. It is an honor to also share my dad’s story.
Change is here for
#SCLC
➡️New tx on the horizon
➡️Lung screening saves lives
➡️Pts are living longer
#LCSM
#hope
#advocacy
@JackWestMD
I would be VERY cautious in interpreting this study for SCLC SOC
@JackWestMD
1) control arm did not include anti-PD-L1, 2) ⬆️ population of never-smokers, 3) ⬇️ population of brain/liver mets, 4) ⬆️ g3/4 AEs, 5) China-only study
@OncoAlert
@LungCancerRx
1/3 Our new
#SCLC
#ICI
#XRT
review (
@SpringerNature
) discusses the role of novel combinations of immune checkpoint inhibitors (ICI) and chemoradiation in limited stage SCLC.
Watch
@drshieldsmd
, of
@IUMedSchool
, preview her insights on emerging treatments for SCLC, which she discussed at the Bridging the Gaps in Lung Cancer meeting! Check out our site for more conference updates!
@gotoPER
#gotoPER
#lcsm
A beautiful Saturday to curl up on the couch with “He Whispered Life,” an inspiring story of hope, awareness, and love by the incredible
@MontessaLee
, a small cell lung cancer survivor and advocate. Thank you for sharing your amazing story!
#LCSM
#SCLC
@SclcSMASHERS
@LiveLung1
@amarkelkar
@MeCookieMonster
Cookie Monster and Gonger are my favorite. Many of hours spent watching Sesame Street with my two kiddos. Definitely my favorite part of each episode!
Some of the many perks to weekend rounds 👩🏼⚕️ on the inpatient
#oncology
service:
✅ finding a good parking spot 🚙
✅ treating yourself to a delicious smoothie from
@TropicalCafe
✅ beautiful sunshine ☀️
✅ caring for our lovely patients ❤️
#LCSM
#medtwitter
#palmsunday
Groundbreaking study by
@Sutherland_Lab
and colleagues challenging the dogma of “YAP1” neuroendocrine subtype in
#SCLC
.
This research finally clarifies how YAP1+ actually appears in SMARCA4-deficient undifferentiated thoracic tumors, not in
#SCLC
.
#LCSM
#researchcurescancer
Interesting multi-omic analysis of previously classified SCLC cell lines (YAP1+), identifies that these tumors represent diseases that ‘mimic’ SCLC- in this case- SMARCA4-deficient thoracic tumors, that have a poor prognosis
@CCR_AACR
@OncoAlert
#LCSM
I am honored to announce that I will be speaking at @ Update on Small Cell Lung Cancer: A Two-Part Workshop Series on May 30 and June 13. For more information or to register, please visit
@CancerCare
@LUNGevity
#lcsm
Thankful for the kind gestures of my wonderful patients and their sweet families.
It is truly an honor to serve as a medical oncologist and to walk together with our patients in their cancer journey.
#cancercannotstealourjoy
#cherisheverymoment
#LCSM
“We need to do BETTER!” Dr. Greg Riley
Avoid negative trials in Oncology:
🚨add active drugs to SOC
🚨design non-inferiority studies
🚨give drugs early without d/c
#TTLC24
@IASLC
@IUCancerCenter
#LCSM
An enlightening and moving presentation from
@drshieldsmd
during Day 2 at
#SCLCSummit2024
. Thank you for sharing your story and research!
Join us virtually for the remainder of Day 2 here
What an amazing time supporting a wonderful foundation, Fair Haven! Today, we had a chance to give back during
#hoosierhospitalityweek
with
@iu_health
and End Lung Cancer Now, by baking warm cookies and providing a handmade quilt donated by the women’s prison!
@IUCancerCenter
Incredible opportunity to host Moffitt CEO & President
@PatrickHwuMD
and MalHeme Faculty Dr. Seongseok Yun
@Prologue
to Moffitt’s Clinical Grant Writing Academy. Our
#CGWA
aims to provide enthusiasm & training w/ Moffitt’s world-class experts for fellows as prep for
#YIA
&
#CDA
.
Let’s reduce operational burdens of
#trials
on our patients!
How can it be done?
@theNCI
#CTAC
will:
⭐️ Identify data/labs w/ low value
⭐️ Eliminate redundancy
⭐️ Streamline standard practices
Final report by
#CTAC
anticipated in March ‘24!
#LCSM
#SCLC
#nothingsmallaboutit